MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
PMCB Income Statement Sankey Diagram
Sankey diagram visualizing PMCB income statement for the period
Net loss
attributable to common...
-$5,785,807
(30.79%↑ Y/Y)
Net loss
-$5,081,191
(39.22%↑ Y/Y)
Preferred stock accretion
$621,217
Preferred stock dividends
$83,399
Total other income
(expense), net
-$4,074,483
(45.76%↑ Y/Y)
Loss from operations
-$1,006,708
(-18.67%↓ Y/Y)
Change in fair value of
warrant liability
$4,221,000
(1637.04%↑ Y/Y)
Change in fair value of
derivative liability
$597,000
Dividend income
$240,884
Interest income
$166,278
(-23.65%↓ Y/Y)
Change in fair value of
investment qcls
-$5,550,000
Total operating
expenses
$1,006,708
(18.67%↑ Y/Y)
Change in fair value of
warrant assets qcls
-$3,181,000
Change in fair value of
warrant asset femasys
-$414,000
(65.93%↑ Y/Y)
Unrealized loss on
marketable securities
-$154,548
(-47.95%↓ Y/Y)
Other expense, net
-$97
(19.83%↑ Y/Y)
General and
administrative
$946,708
(25.70%↑ Y/Y)
Research and development
costs
$60,000
(-36.95%↓ Y/Y)
Back
Back
PharmaCyte Biotech, Inc. (PMCB)
PharmaCyte Biotech, Inc. (PMCB)
Income Statement
Quarterly Income Statement for the quarter ending in 2026-07-31
source: myfinsight.com